For more information or confidential assistance
800-306-3180
se habla español

Jacky Gale

Since beginning her journalism career with a focus on the healthcare industry, Jacky has written extensively about the dangers of many popular medications, including Actos, Yaz, Xarelto and more.

Diabetic Ketoacidosis Prompts Invokana Lawsuit

drugreporter.com
A California woman has filed a product lability lawsuit against Janssen Pharmaceuticals and Johnson & Johnson, alleging that the defendants’ product, Invokana, caused serious complications. Jennifer Anzo filed the Invokana lawsuit late in October 2015 in the U.S. District Court for the Eastern District of California. She is demanding compensation... Read more »

Hundreds of Yaz Lawsuits Resolved with Settlements

yaz packaging
Bayer Healthcare Pharmaceuticals has reported substantial progress during the latest status conference for the multidistrict litigation (MDL) No. 2100 regarding Yaz and Yasmin lawsuits. The status conference took place early in November 2015. It was presided over by U.S. District Judge David R. Herndon of the Southern District of Illinois.... Read more »

FDA Declines Approval of New Combination Diabetes Drug

London-based AstraZeneca failed to obtain FDA approval for a proposed diabetes drug that combines two different medications, saxagliptin and dapagliflozin. In October 2015, the FDA issued a complete response letter to the pharmaceutical giant’s application. The agency requested additional clinical research on the proposed combination drug. AstraZeneca recently released statements... Read more »

Judge Remands Talc Lawsuits to State Court

A federal judge has issued an order to remand three talc-related cancer lawsuits back to Missouri state court. The lawsuits represent 237 plaintiffs who claim that their diagnoses of ovarian cancer were linked to their use of talcum powder products. In October 2015, U.S. District Judge Catherine Perry rejected the... Read more »

FDA Updates Invokana Label Regarding Bone Fracture Risk

drugreporter.com
The U.S. Food and Drug Administration (FDA) has released a new drug safety communication regarding Invokana and Invokamet (canagliflozin). The safety announcement, which was released on September 10, 2015, adds a new warning to the drug’s label and updates the adverse reactions section with regard to the risk of bone... Read more »

Does Testosterone Therapy Contribute to Atherosclerosis?

Byetta pancreatic cancer patient
The use of testosterone replacement therapy (TRT) has been increasing, yet some have expressed concerns about potentially life-threatening side effects of testosterone gels, creams, patches, and other products. Cardiovascular complications are of particular concern. Some men have filed lawsuits against a handful of TRT product manufacturers, claiming that the drugs... Read more »